Cross-reactivity

Development and performance of a point-of-care rapid antigen test for detection of SARS-CoV-2 variants

Unique construction of a point-of-care rapid antigen test using two pairs of monoclonal antibodies has led to good performance that remained durable across multiple variants in laboratory and clinical evaluations. Test should identify almost all individuals harboring infectious SARS-CoV-2.